Evidence map›Paper›PMID 10981040›Full record

ReviewCurrent hypertension reports

Angiotensinogen variants and human hypertension.

X Jeunemaitre, A P Gimenez-Roqueplo, J Célérier, P Corvol

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current hypertension reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Cardiovascular Research in France.Circulation research · 2018
    Article
  5. Review
  6. Review
  7. The "his and hers" of the renin-angiotensin system.Current hypertension reports · 2013
    Review
  8. Article
  9. The genetics of white matter lesions.CNS neuroscience & therapeutics · 2011
    Review
  10. Article
  11. Genetics of the human renin angiotensin system.Journal of molecular medicine (Berlin, Germany) · 2008
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

X JeunemaitreINSERM U36, Collège de France - 3, rue d"Ulm, 75005 Paris, France.
A P Gimenez-Roqueplo
J Célérier
P Corvol
Collège de France · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The research on molecular genetics of human hypertension aims to identify the loci involved in the regulation of blood pressure, detect gene variants within the identified loci, associate them with intermediate phenotypes, and ultimately estimate their quantitative effects on blood pressure level and their interaction with main environmental factors. So far, the angiotensinogen (AGT) gene is one of the few candidate genes that has been investigated using these multiple statistical, clinical, and biochemical strategies. A highly polymorphic dinucleotide GT repeat (80% heterozygosity) has been used in several linkage studies. Other diallelic polymorphisms, located in the 5' regulatory region of the gene in intronic and exonic sequences, have been described, which were then used in association studies in different clinical settings. Positive associations between the M235T and the G-6A polymorphisms and plasma angiotensinogen levels indicates a pathway by which the AGT locus could be involved in essential hypertension.

Indexed as

Genetic VariationAngiotensinogenChromosome MappingDinucleotide RepeatsHumansHypertensionPolymorphism, GeneticAngiotensinogen

Identifiers

PMID10981040
OpenAlexW1974311264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.